Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013821 |
---|---|
Receipt number | R000016070 |
Scientific Title | A phase I/II study of preoperative TS-1 combined chemoradiation therapy for patients with large type 3 or type 4 gastric cancer (OGSG 1303) |
Date of disclosure of the study information | 2014/04/28 |
Last modified on | 2020/01/22 22:26:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/04/27 17:47:20 | ||
2 | Update | 2014/10/27 23:19:46 | Anticipated trial start date |
|
3 | Update | 2014/10/27 23:21:15 | Institutions |
|
4 | Update | 2015/01/28 02:37:39 | Institute |
|
5 | Update | 2015/01/28 02:39:53 | Institutions |
|
6 | Update | 2015/01/28 02:40:27 | ||
7 | Update | 2015/01/28 02:52:46 | Key inclusion criteria Key inclusion criteria |
|
8 | Update | 2015/05/30 09:41:09 | Email Institutions |
|
9 | Update | 2015/10/28 13:20:59 | Institutions |
|
10 | Update | 2016/10/19 23:04:15 | Name of primary person or sponsor Organization Organization |
|
11 | Update | 2017/08/20 00:53:34 | Last follow-up date |
|
12 | Update | 2017/08/20 01:03:50 | Organization Organization Organization Organization |
|
13 | Update | 2017/08/20 01:05:34 | Institutions |
|
14 | Update | 2018/04/30 23:59:52 | Email |
|
15 | Update | 2018/05/10 20:36:13 | Email |
|
16 | Update | 2018/08/01 21:35:22 | UMIN ID1 |
|
17 | Update | 2018/08/01 21:38:23 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
18 | Update | 2018/10/07 13:46:56 | Recruitment status Last follow-up date |
|
19 | Update | 2018/10/30 20:25:40 | Last follow-up date Date analysis concluded |
|
20 | Update | 2020/01/05 20:55:24 | Date of IRB Last follow-up date Date analysis concluded |
|
21 | Update | 2020/01/05 20:56:09 | Number of participants that the trial has enrolled |
|
22 | Update | 2020/01/22 22:26:19 | Recruitment status |